JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marcus, F. I.
Right arrow Articles by Kapadia, G. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marcus, F. I.
Right arrow Articles by Kapadia, G. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Blood and Blood Disorders
*Urine and Urination
Hazardous Substances DB
*DIGOXIN
Journal of Pharmacology And Experimental Therapeutics, Vol. 145, Issue 2, 203-209, 1964
Copyright © 1964 by American Society for Pharmacology and Experimental Therapeutics


THE METABOLISM OF DIGOXIN IN NORMAL SUBJECTS

Frank I. Marcus 1, Govind J. Kapadia 1, and Geeta G. Kapadia 1

1 Cardiology Laboratory, Georgetown Medical Division, District of Columbia General Hospital, Washington, D. C.

Four healthy young subjects were given tritiated digoxin intravenously. Serial blood samples were analyzed for total activity. Selected samples of blood, urine and stool were partitioned by alumina column chromatography for differentiation of the digoxin fraction from the metabolites. Further identification of the digoxin fraction in urinary extracts was obtained by paper chromatography.

There was a rapid disappearance from the blood. Three minutes after injection, only 15.9% of the total dose injected remained in the blood, of which 90% was recovered in the 20% ethanol in chloroform eluate. In 1 hour, only 2.8% was present.

The main route of elimination of digoxin was by way of the kidneys. Of the total dose, 26.8% was excreted in the urine in the first 24 hours, 93.9% in the form of digoxin. The urinary half-time was 1.8 days.

The stool excretion accounted for an average of 14.8% of the dose. Metabolic products represented 14% of the dose excreted by the fecal route in the second day sample.

There was a close correlation between the calculated half-time in urine and stool to the duration of clinical effect. This suggests that data obtained in metabolic studies which show an impairment of digoxin metabolism may be reflected in an increased duration of action. Under these circumstances, a cumulative effect would be anticipated if the usual daily maintenance dose is administered.

Accepted on April 8, 1964







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1964 by the American Society for Pharmacology and Experimental Therapeutics.